Rimas Orentas
Immunotherapy R&D - looking to develop immunotherapy, cell and gene therapy, and make an end to sickle cell disease.
@biorxiv-cancer.bsky.social
@aaas.org
Advancing science, serving society. One of the world’s largest general scientific societies and publisher of @science.org
@asgct.bsky.social
Advancing knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease.
@biorxiv-immuno.bsky.social
@ascaa.bsky.social
ASCAA is a 501(c)3 non-profit organization assisting people with sickle cell anemia since 1971. ASCAA provides testing, counseling, education (at multiple levels), resources, and more. www.ascaa.org https://linktr.ee/americansicklecellanemia
@forum-gd.bsky.social
Forum for basic and clinical researchers interested in the biology of gamma/delta T cells and their role in the immune system.
@nickvitanza.bsky.social
Scientific Director of Seattle Children's Brain Tumor Research Program Neuro-oncologist & Scientist focused on biologic vulnerabilities of #DIPG & #CARTcell #immunotherapy
@bsky.app
official Bluesky account (check username👆) Bugs, feature requests, feedback: [email protected]